Gensight Biologics SA (SIGHT) — Financial Flexibility Index
Gensight Biologics SA (SIGHT) has a Financial Flexibility Index of -0.07x as of June 2025. Free cash flow of €-2.68 Million (operating CF €-2.68 Million minus capex €0.00) represents 0% of total liabilities (€39.46 Million). Also explore SIGHT year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gensight Biologics SA Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Gensight Biologics SA across 12 annual periods. Check how strategically is Gensight Biologics SA's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Gensight Biologics SA (2013–2024)
Year-by-year free cash flow to debt coverage for Gensight Biologics SA. For the full company profile including market capitalisation, see Gensight Biologics SA market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.34x | €-12.94 Million | €-12.94 Million | €37.68 Million | ▲ +44.5% |
| 2023 | -0.62x | €-24.65 Million | €-24.66 Million | €39.83 Million | ▲ +23.9% |
| 2022 | -0.81x | €-33.50 Million | €-33.75 Million | €41.22 Million | ▼ -93.2% |
| 2021 | -0.42x | €-17.11 Million | €-17.14 Million | €40.66 Million | ▲ +0.1% |
| 2020 | -0.42x | €-15.04 Million | €-15.04 Million | €35.69 Million | ▲ +68.8% |
| 2019 | -1.35x | €-28.04 Million | €-28.11 Million | €20.74 Million | ▲ +35.8% |
| 2018 | -2.10x | €-27.59 Million | €-28.38 Million | €13.11 Million | ▲ +18.1% |
| 2017 | -2.57x | €-18.55 Million | €-18.78 Million | €7.22 Million | ▲ +22.2% |
| 2016 | -3.30x | €-19.45 Million | €-19.64 Million | €5.89 Million | ▼ -102.5% |
| 2015 | -1.63x | €-11.39 Million | €-12.09 Million | €6.98 Million | ▼ -29.7% |
| 2014 | -1.26x | €-5.33 Million | €-5.52 Million | €4.24 Million | ▼ -49.1% |
| 2013 | -0.84x | €-1.61 Million | €-1.95 Million | €1.91 Million | — |